PA
CXM icon

PharVision Advisers’s Sprinklr CXM Stock Holding History

PharVision Advisers’s Portfolio CXM Stock Details CXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-34,307
Closed -$265K – 750
2025
Q3 		$265K Sell
34,307
-13,984
-29% -$118K 0.15% 300
2025
Q2 		$409K Buy
48,291
+25,536
+112% +$204K 0.59% 25
2025
Q1 		$190K Buy
+22,755
New +$199K 0.26% 203

Other funds holding CXM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HFCII
H&F Corporate Investors IX San Francisco, California $65.2M AUM 28.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
SP
Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return

PharVision Advisers's CXM Position: Q4 2025 in Review

PharVision Advisers sold out of Sprinklr (CXM) in Q4 2025, closing a stake of 34,307 shares — an estimated $265K sold.

PharVision Advisers first reported a position in CXM in Q1 2025 and held it in 3 quarters. The position peaked at $409K in Q2 2025. 267 funds tracked by Wall St. Rank hold CXM as of Q4 2025.

  • PharVision Advisers reported no remaining Sprinklr position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 34,307 Sprinklr shares in Q4 2025, an estimated $265K.
  • PharVision Advisers first reported a position in Sprinklr in Q1 2025 and held it in 3 quarters.
  • PharVision Advisers's Sprinklr position peaked at $409K in Q2 2025.
  • 267 funds tracked by Wall St. Rank held Sprinklr as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.